ClinVar Miner

Submissions for variant NM_005327.7(HADH):c.171C>A (p.Asp57Glu)

gnomAD frequency: 0.00001  dbSNP: rs137853102
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard RCV001762038 SCV001999894 uncertain significance Hyperinsulinemic hypoglycemia, familial, 4 2021-11-02 criteria provided, single submitter curation The p.Asp57Glu variant in HADH has been reported in 2 individuals with familial hyperinsulinemic hypoglycemia (PMID: 32876354, 16725361) and has been identified in in 0.002% (2/113718) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs137853102). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (Variation ID#: 8019) and has been interpreted as pathogenic by OMIM. In vitro functional studies provide some evidence that the p.Asp57Glu variant may slightly impact protein function (PMID: 16725361). However, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. The p.Asp57Glu variant is located in a region of HADH that is essential to protein folding and stability, suggesting that this variant is in a functional domain and slightly supports pathogenicity (PMID: 16725361). In summary, while there is some suspicion for a pathogenic role, the clinical significance of this variant is uncertain. ACMG/AMP Criteria applied: PM2_supporting, PP3, PM1_supporting, PS3_supporting (Richards 2015).
Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic RCV003221347 SCV003915691 uncertain risk allele Hyperinsulinemic hypoglycemia criteria provided, single submitter research Potent mutations in HADH gene are associated with congenital hyperinsulinism, which leads to recurrent hypoglycemia. The condition is exacerbated by stress, fasting or excessive dietary protein. May respond well to diazoxide. However, the role of this particular variant rs137853102 in congenital hyperinsulinism is yet to be ascertained.
OMIM RCV000008483 SCV000028691 pathogenic Deficiency of 3-hydroxyacyl-CoA dehydrogenase 2015-08-18 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.